Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03375151
Other study ID # CLD13
Secondary ID
Status Not yet recruiting
Phase N/A
First received December 13, 2017
Last updated December 13, 2017
Start date February 2018
Est. completion date April 2019

Study information

Verified date December 2017
Source Brainmarc Ltd.
Contact Goded Shahaf, Dr.
Phone 97246660676
Email goded@brainmarc.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The problem of cognitive decline among the aging population has become a significant health burden, especially in light of the increase in the prevalence of dementia with age For patients with MCI (Mild cognitive impairment) there are various recommendations to deal with the disorder, including behavioral recommendations for physical exercise. Some recommendations could also be found for cognitive practice. However, currently, there is no consensus regarding effective cognitive treatment or practice for MCI. Among the populations suffering from MCI, there is a significant segment of patients with amnestic disorder. For these patients, it seems that cognitive training of memory, including verbal memory, is very important. In recent years, we have developed an effective tool for managing rehabilitation practice by monitoring the patient's engagement with an easy-to-use EEG (electroencephalogram) tool. We have shown in a variety of rehabilitation settings, that when the patient is recruited, the clinical improvement is significantly better. The aim of this study is to evaluate the ability to harness the EEG monitoring of brain engagement to achieve functional improvement in verbal memory training in patients with Amnestic MCI.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date April 2019
Est. primary completion date February 2019
Accepts healthy volunteers No
Gender All
Age group 65 Years to 120 Years
Eligibility Inclusion Criteria:

- Male or female above the age of 65 years

- Ability to read, write and understand the Hebrew language so to comply with study demands.

- Diagnosed with Amnestic MCI. Mini Mental State Examination (MMSE), A score of MSSE =27 for college educated subjects and MSSE = 26 for all others; and (CDR) Clinical Dementia Rating, 0.5 = CDR

- Diagnosed with memory impairment, Visual Paired Association = VPA (WMS-R), for subjects of ages 65-70, 16.5 = WMS-R and for subjects of age above 71, 15.5 = WMS-R

Exclusion Criteria:

- Diagnosed with major psychiatric or neurological disorder.

- A user of recreational or illicit drugs or has had a recent history of drug or alcohol abuse or dependence.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
EEG based feedback
Participants will participate in cognitive training sessions. The therapist will use feedback from the EEG analyzed data to direct the cognitive therapy based on the therapist's guidance to maximize the intensity and duration of the patient's high brain engagement Index (BEI) during exercise.
Behavioral:
Standard practice based feedback
Participants will participate in cognitive training sessions. The therapist will give feedback to the participants during the exercise based on their performance only according to the his therapist standard practice.
No feedback
Participants will participate in cognitive training sessions. The therapist will not guide them during the sessions.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Brainmarc Ltd.

Outcome

Type Measure Description Time frame Safety issue
Primary Cognitive test grade The difference in grades in a test for evaluation cognitive abilities in a textual assignment between the beginning and the end of the study. up to 5 weeks
Secondary Rey Auditory-Verbal Learning Test The difference in grades of Free And Cued Selective Reminding Test (FCSRT) score between the beginning and the end of the study. up to 5 weeks
Secondary Free And Cued Selective Reminding Test The difference in grades of Rey Auditory-Verbal Learning Test (RAVLT) score between the beginning and the end of the study. up to 5 weeks
Secondary Rivermead Behavioral Memory Test The difference in grades of Rivermead Behavioral Memory Test (RBMT) score between the beginning and the end of the study. up to 5 weeks
Secondary Clinical Global Impression of Change The difference in grades of Clinical Global Impression of Change (CGI-C) score between the beginning and the end of the study. up to 5 weeks
See also
  Status Clinical Trial Phase
Completed NCT04513106 - Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial N/A
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Active, not recruiting NCT03167840 - Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment N/A
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Not yet recruiting NCT05041790 - A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment Phase 4
Recruiting NCT04121156 - High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment N/A
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Completed NCT02774083 - Cognitive Training Using Feuerstein Instrumental Enrichment N/A
Completed NCT01315639 - New Biomarker for Alzheimer's Disease Diagnostic N/A
Enrolling by invitation NCT06023446 - Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
Completed NCT04567745 - Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers Phase 1
Recruiting NCT05579236 - Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
Completed NCT03583879 - Using Gait Robotics to Improve Symptoms of Parkinson's Disease N/A
Terminated NCT02503501 - Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease Phase 2
Not yet recruiting NCT03740178 - Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) Phase 1
Active, not recruiting NCT05204940 - Longitudinal Observational Biomarker Study
Recruiting NCT02663531 - Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Recruiting NCT03507192 - Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia. N/A